4.6 Article

CDKN2A inhibits formation of homotypic cell-in-cell structures

期刊

ONCOGENESIS
卷 7, 期 -, 页码 -

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/s41389-018-0056-4

关键词

-

类别

资金

  1. National Key Research & Development Program of China [2016YFC1303303]
  2. National Basic Research Program of China [2015CB553704]
  3. National Major Scientific and Technological Special Project for Significant New Drugs Development [2015ZX09501-009]
  4. National Natural Science Foundation of China [81472588, 31671432, 81471578, 31770975, 81572799, 81372834]
  5. Beijing Health System High-level Health Technical Personnel Training Project [2015-3-058]
  6. Beijing Municipal Natural Science Foundation [7162091]

向作者/读者索取更多资源

Cell-in-cell (CIC) structures, characterized by enclosure of one or more cells within another cell, were extensively documented in human cancers. Although elevated CIC formation was found in cancers with CDKN2A inactivation, a causal link between them remains to be established. We reported here that inhibiting CDKN2A expression effectively promoted homotypic CIC formation, whereas ectopic overexpression of p16INK4a or p14ARF, two proteins encoded by CDKN2A gene, significantly suppressed CIC formation in MCF7 cells. The regulation of CIC formation by CDKN2A was tightly correlated with subcellular redistribution of E-cadherin, F-actin rearrangement and reduced phosphorylation of myosin light chain 2 (p-MLC2), consistent with which, CDKN2A expression imparted cells winner/outer identity in competition assay. Moreover, CIC formation negatively correlates with p16INK4a expression in human breast cancers. Thus, our work identifies CDKN2A as the first tumor suppressor whose inactivation promotes homotypic CIC formation in human cancer cells.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据